Doctor profile · Federal record

Dr. Caryn Hasselbring, M.D.

Rheumatology Physician (CMS: Rheumatology) · Orlando, FL

  • NPI 1124086699
  • MIPS 94.3 / 100 · 2023
  • 44 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3160 Southgate Commerce Blvd, Ste 30
Orlando, FL 328068549
(407) 859-4540
fax (407) 859-3815

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
October 12, 2011
Year of graduation
1982 — 44 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Florida #ME0051093
Medicaid
FL #046298500

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1124086699. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
13,389
Distinct HCPCS
10
Medicare allowed
$482,840
HCPCS Description Services Patients Avg allowed
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 5,900 14 $40
J0897 Injection, denosumab, 1 mg 4,260 45 $22
J1745 Injection, infliximab, excludes biosimilar, 10 mg 1,725 11 $32
99214 Established patient office or other outpatient visit, 30-39 minutes 362 147 $119
36415 Insertion of needle into vein for collection of blood sample 253 123 $3
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 236 56 $67
96413 Administration of chemotherapy into vein, 1 hour or less 186 51 $119
96415 Administration of chemotherapy into vein, each additional hour 141 24 $26
96375 Injection of additional new drug or substance into vein 110 24 $14
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 63 24 $5

In context: peer comparison

Among 12 peers in Orlando Rheumatology Physician, average services per provider: 1,121. This provider delivers 12× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,553
Transactions
119
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 27 $461.51
Janssen Biotech, INC. 14 $374.33
Pfizer INC. 17 $248.94
Novartis Pharmaceuticals Corporation 12 $237.21
Abbvie INC. 10 $224.03
Ucb, INC. 11 $194.64
Lilly USA, LLC 6 $107.66
AstraZeneca Pharmaceuticals Lp 4 $93.95
Boehringer Ingelheim Pharmaceuticals, INC. 3 $76.73
Aurinia Pharma U.S., INC. 4 $71.84
GlaxoSmithKline, LLC. 4 $69.58
Genzyme Corporation 2 $60.02
Sandoz INC. 2 $54.82
Bioventus LLC 1 $44.18
Alexion Pharmaceuticals, INC. 2 $38.70

By nature of payment

Food and Beverage
$2,553

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
982
Patients
289
Total drug cost
$29,216
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 149 47 $5,178
Duloxetine Hcl Generic 101 26 $3,910
Meloxicam Generic 96 31 $642
Hydroxychloroquine Sulfate Generic 87 31 $6,535
Gabapentin Generic 71 23 $1,988
Celecoxib Generic 64 20 $3,466
Tramadol Hcl Generic 59 19 $458
Folic Acid Generic 55 17 $283
Pregabalin Generic 54 13 $2,634
Vitamin D2 (Ergocalciferol (Vitamin D2)) Brand 53 21 $298

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Caryn Hasselbring's medical specialty?
Dr. Caryn Hasselbring practices Rheumatology Physician in Orlando, FL.
Where does Dr. Caryn Hasselbring practice?
Dr. Caryn Hasselbring practices at 3160 Southgate Commerce Blvd, Orlando, FL 328068549. Office phone: 4078594540.
What is Dr. Caryn Hasselbring's NPI?
Dr. Caryn Hasselbring's National Provider Identifier (NPI) is 1124086699, issued by NPPES.
Does Dr. Caryn Hasselbring accept Medicare assignment?
Dr. Caryn Hasselbring does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Caryn Hasselbring commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, denosumab, 1 mg (HCPCS J0897); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.